1
|
Rizzi A, Gammeri L, Cordiano R, Valentini M, Centrone M, Marrone S, Inchingolo R, Lohmeyer FM, Cavaliere C, Ria F, Cadoni G, Gangemi S, Nucera E. Therapeutic Strategies to Prevent the Recurrence of Nasal Polyps after Surgical Treatment: An Update and In Vitro Study on Growth Inhibition of Fibroblasts. J Clin Med 2023; 12:jcm12082841. [PMID: 37109177 PMCID: PMC10142691 DOI: 10.3390/jcm12082841] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2023] [Revised: 04/05/2023] [Accepted: 04/10/2023] [Indexed: 04/29/2023] Open
Abstract
Chronic rhinosinusitis with nasal polyps (CRSwNP) is the most bothersome phenotype of chronic rhinosinusitis, which is typically characterized by a Type 2 inflammatory reaction, comorbidities and high rates of nasal polyp recurrence, causing severe impact on quality of life. Nasal polyp recurrence rates, defined as the number of patients undergoing revision endoscopic sinus surgery, are 20% within a 5 year period after surgery. The cornerstone of CRSwNP management consists of anti-inflammatory treatment with local corticosteroids. We performed a literature review regarding the therapeutic strategies used to prevent nasal polyp recurrence after surgical treatment. Finally, we report an in vitro study evaluating the efficacy of lysine-acetylsalicylic acid and other non-steroidal anti-inflammatory drugs (ketoprofen and diclofenac) on the proliferation of fibroblasts, obtained from nasal polyp tissue samples. Our study demonstrates that diclofenac, even more so than lysine-acetylsalicylic acid, significantly inhibits fibroblast proliferation and could be considered a valid therapeutic strategy in preventing CRSwNP recurrence.
Collapse
Affiliation(s)
- Angela Rizzi
- UOSD Allergologia e Immunologia Clinica, Dipartimento Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy
| | - Luca Gammeri
- Department of Clinical and Experimental Medicine, School and Operative Unit of Allergy and Clinical Immunology, University of Messina, 98125 Messina, Italy
| | - Raffaele Cordiano
- Department of Clinical and Experimental Medicine, School and Operative Unit of Allergy and Clinical Immunology, University of Messina, 98125 Messina, Italy
| | - Mariagrazia Valentini
- Department of Obstetrics and Gynecology, Catholic University of the Sacred Heart, 00168 Rome, Italy
- Division of Gynecologic Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy
| | - Michele Centrone
- UOSD Allergologia e Immunologia Clinica, Dipartimento Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy
| | - Sabino Marrone
- Otorhinolaryngology Unit, Head and Neck Department, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy
| | - Riccardo Inchingolo
- UOC Pneumologia, Dipartimento Neuroscienze, Organi di Senso e Torace, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy
| | | | - Carlo Cavaliere
- Department of Sense Organs, Sapienza University, 00185 Rome, Italy
| | - Francesco Ria
- Section of General Pathology, Department of Translational Medicine and Surgery, Università Cattolica del Sacro Cuore, Largo Francesco Vito 1, 00168 Rome, Italy
- Department Laboratory and Infectious Diseases Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo Agostino Gemelli 1-8, 00168 Rome, Italy
| | - Gabriella Cadoni
- Otorhinolaryngology Unit, Head and Neck Department, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy
- Otolaryngology Institute, Università Cattolica del Sacro Cuore, 00168 Rome, Italy
| | - Sebastiano Gangemi
- Department of Clinical and Experimental Medicine, School and Operative Unit of Allergy and Clinical Immunology, University of Messina, 98125 Messina, Italy
| | - Eleonora Nucera
- UOSD Allergologia e Immunologia Clinica, Dipartimento Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy
- Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, 00168 Rome, Italy
| |
Collapse
|
2
|
Abstract
Allergy to natural rubber latex (NRLA) from Hevea brasiliensis is a relevant public health issue, in particular in healthcare workers and groups at risk. Clinical manifestations of NRLA can range from mild skin disorders to life-threatening systemic reactions. Prevention measures remain the gold-standard treatment for patients suffering from NRLA, but the only etiological therapy able to influence the natural history of NRLA is specific desensitization. This review aims to underline the epidemiological, clinical and diagnostic aspects of NRLA, and carries out a complete and wide-ranging review of the current literature on NRLA management and immunotherapy.
Collapse
Affiliation(s)
- Eleonora Nucera
- Allergy Unit, Fondazione Policlinico Universitario A. Gemelli IRCSS, Università Cattolica del Sacro Cuore, Rome, Italy
| | - Arianna Aruanno
- Allergy Unit, Fondazione Policlinico Universitario A. Gemelli IRCSS, Università Cattolica del Sacro Cuore, Rome, Italy
| | - Angela Rizzi
- Allergy Unit, Fondazione Policlinico Universitario A. Gemelli IRCSS, Università Cattolica del Sacro Cuore, Rome, Italy
| | - Michele Centrone
- Allergy Unit, Fondazione Policlinico Universitario A. Gemelli IRCSS, Università Cattolica del Sacro Cuore, Rome, Italy
| |
Collapse
|
3
|
Rizzi A, Di Rienzo A, Buonomo A, Aruanno A, Carusi V, Ricci AG, Centrone M, Mezzacappa S, Romeo L, Schiavino D, Inchingolo R, Gasbarrini A, Nucera E. Impact of nickel oral hyposensitization on quality of life in systemic nickel allergy syndrome. Int J Immunopathol Pharmacol 2020; 34:2058738420934629. [PMID: 32567420 PMCID: PMC7309377 DOI: 10.1177/2058738420934629] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
Nickel (Ni) oral hyposensitization treatment (NiOHT) is an effective management approach for Ni allergy. No health-related quality of life (HRQoL) data exist for the pre- and post-treatment with NiOHT in systemic nickel allergy syndrome (SNAS). The aims of this study were (a) to explore HRQoL in SNAS patients, (b) to assess changes of HRQoL after 1 year of NiOHT; (c) to evaluate psychological status of patients. SNAS patients completed the Short-Form 36-Item Health Survey and Psychological General Well-Being Index before and 1 week after the end of NiOHT. Moreover, psychological state was assessed with the Minnesota Multiphasic Personality Inventory (MMPI-2). A total of 52 patients self-reported pre- and post-treatment questionnaires. HRQoL was poor at baseline. After 1 year of NiOHT, all outcome measure scores improved by about 20% with respect to baseline data (P < 0.01 for all indices, except depressed mood). Finally, 33 patients performed the MMPI-2. High rates for hypochondriasis and depression were noted. Furthermore, most of the patients had high scores for anxiety, depression, and health concerns. This is the first study showing that NiOHT improves HRQoL of SNAS patients, which can be considered a “personalized medicine” approach.
Collapse
Affiliation(s)
- Angela Rizzi
- Unità di Allergologia e Immunologia Clinica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italia
| | - Alessia Di Rienzo
- Unità di Allergologia e Immunologia Clinica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italia
| | - Alessandro Buonomo
- Unità di Allergologia e Immunologia Clinica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italia
| | - Arianna Aruanno
- Unità di Allergologia e Immunologia Clinica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italia
| | - Valentina Carusi
- Unità di Allergologia e Immunologia Clinica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italia
| | - Anna Giulia Ricci
- Unità di Allergologia e Immunologia Clinica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italia
| | - Michele Centrone
- Unità di Allergologia e Immunologia Clinica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italia
| | | | | | - Domenico Schiavino
- Unità di Allergologia e Immunologia Clinica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italia
| | - Riccardo Inchingolo
- Unità Operativa Complessa di Pneumologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italia
| | - Antonio Gasbarrini
- Unità Operativa Complessa di Gastroenterologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italia.,Unità Operativa Complessa di Gastroenterologia, Università Cattolica del Sacro Cuore, Roma, Italia
| | - Eleonora Nucera
- Unità di Allergologia e Immunologia Clinica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italia.,Unità di Allergologia e Immunologia Clinica, Università Cattolica del Sacro Cuore, Roma, Italia
| |
Collapse
|
4
|
Nucera E, Chini R, Buonomo A, Centrone M, Aruanno A, Schiavino D. Efficacy of long-term treatment with omalizumab in a food and inhalant allergy patient. Postepy Dermatol Alergol 2020; 37:441-442. [PMID: 32792891 PMCID: PMC7394165 DOI: 10.5114/ada.2020.96111] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/07/2019] [Accepted: 03/20/2019] [Indexed: 11/17/2022] Open
Affiliation(s)
- Eleonora Nucera
- Allergy Unit, Fondazione Policlinico Universitario A. Gemelli - IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy
| | - Raffaella Chini
- Allergy Unit, Fondazione Policlinico Universitario A. Gemelli - IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy
| | - Alessandro Buonomo
- Allergy Unit, Fondazione Policlinico Universitario A. Gemelli - IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy
| | - Michele Centrone
- Allergy Unit, Fondazione Policlinico Universitario A. Gemelli - IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy
| | - Arianna Aruanno
- Allergy Unit, Fondazione Policlinico Universitario A. Gemelli - IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy
| | - Domenico Schiavino
- Allergy Unit, Fondazione Policlinico Universitario A. Gemelli - IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy
| |
Collapse
|
5
|
Pandolfi F, Franza L, Todi L, Carusi V, Centrone M, Buonomo A, Chini R, Newton EE, Schiavino D, Nucera E. The Importance of Complying with Vaccination Protocols in Developed Countries: "Anti-Vax" Hysteria and the Spread of Severe Preventable Diseases. Curr Med Chem 2019; 25:6070-6081. [PMID: 29773050 DOI: 10.2174/0929867325666180518072730] [Citation(s) in RCA: 20] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/28/2017] [Revised: 03/11/2018] [Accepted: 05/14/2018] [Indexed: 11/22/2022]
Abstract
BACKGROUND Vaccines are very effective medical tools for disease prevention and life span increase. Controversies have raised concern about their safety, from autism to polio vaccine contamination with simian virus 40 (SV-40). Hysteria surrounding vaccine-associated risks has resulted in a declining number of vaccinations in developed countries. Outbreaks of vaccine-preventable diseases (e.g. measles) have occurred in Europe and North America, causing also some causalities. OBJECTIVES In this review, data on safety and efficacy of vaccines are discussed, showing that the benefits of vaccines far outweigh the risks and that it is important to comply with vaccination protocols, to avoid spreading of severe, preventable diseases. METHODS Those opposed to vaccinations suggest that scientific literature supporting vaccines is influenced by pharmaceutical companies. In this review, studies on influenza produced by independent scientists and those authored by those who received some kind of benefit from the industry are discussed separately. All the chosen papers were selected through a MEDLINE research. RESULTS Vaccination rates are decreasing, even though they are effective public health tools. Influenza, for example, is responsible for 250,000-500,000 deaths each year, according to the WHO. Yet, campaigns to extend influenza vaccine to all elderly subjects report little success, because of the vaccine scare and because not all patients develop immunity following vaccination. CONCLUSIONS This review proves that vaccine hysteria is detrimental because: 1) it causes an increased morbidity and mortality from preventable diseases; 2) it jeopardizes research for new vaccines; 3) patients are reluctant to accept any form of immune-therapy, commonly referred to as "vaccination".
Collapse
Affiliation(s)
- F Pandolfi
- Department of Internal Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS - Universita Cattolica del Sacro Cuore, Roma, Italy
| | - L Franza
- Department of Internal Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS - Universita Cattolica del Sacro Cuore, Roma, Italy
| | - L Todi
- Department of Internal Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS - Universita Cattolica del Sacro Cuore, Roma, Italy
| | - V Carusi
- Department of Internal Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS - Universita Cattolica del Sacro Cuore, Roma, Italy
| | - M Centrone
- Department of Internal Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS - Universita Cattolica del Sacro Cuore, Roma, Italy
| | - A Buonomo
- Department of Internal Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS - Universita Cattolica del Sacro Cuore, Roma, Italy
| | - R Chini
- Department of Internal Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS - Universita Cattolica del Sacro Cuore, Roma, Italy
| | | | - D Schiavino
- Department of Internal Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS - Universita Cattolica del Sacro Cuore, Roma, Italy
| | - E Nucera
- Department of Internal Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS - Universita Cattolica del Sacro Cuore, Roma, Italy
| |
Collapse
|
6
|
Nucera E, Mezzacappa S, Buonomo A, Centrone M, Rizzi A, Manicone PF, Patriarca G, Aruanno A, Schiavino D. Latex immunotherapy: evidence of effectiveness. Postepy Dermatol Alergol 2018; 35:145-150. [PMID: 29760613 PMCID: PMC5949543 DOI: 10.5114/ada.2018.75235] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2016] [Accepted: 02/15/2017] [Indexed: 11/18/2022] Open
Abstract
INTRODUCTION The only etiological and decisive therapy, able to influence the natural history of latex allergy is the specific desensitization. AIM To verify the clinical efficacy and immunological changes determined by latex sublingual immunotherapy in allergic patients who underwent this treatment for at least 3 years. MATERIAL AND METHODS We enrolled 76 patients (16 males and 60 females, mean age 34 years old) with evidence of a natural rubber latex allergy. To assess the effectiveness of the immunotherapy we performed a latex skin prick test, specific IgE and IgG4 and challenge tests before and after at least 3 years of desensitization. RESULTS We observed a reduction in the mean diameter of the wheal area at the skin prick test and a decrease in latex specific IgE while no significant changes of latex IgG4 values were found. Moreover a reduction of symptoms and scores at the provocation tests were remarked. CONCLUSIONS Although the primary prevention (which still remains the gold standard treatment for patients suffering from the latex allergy) sublingual immunotherapy can be offered with efficacy in addition to symptomatic treatment to selected patients.
Collapse
Affiliation(s)
- Eleonora Nucera
- Allergy Unit, Università Cattolica del Sacro Cuore – Fondazione Policlinico “A. Gemelli”, Rome, Italy
| | - Simona Mezzacappa
- Allergy Unit, Università Cattolica del Sacro Cuore – Fondazione Policlinico “A. Gemelli”, Rome, Italy
| | - Alessandro Buonomo
- Department of Head and Neck, Division of Oral Surgery and Implantology, Fondazione Policlinico Universitario Gemelli, Rome, Italy
| | - Michele Centrone
- Department of Head and Neck, Division of Oral Surgery and Implantology, Fondazione Policlinico Universitario Gemelli, Rome, Italy
| | - Angela Rizzi
- Department of Head and Neck, Division of Oral Surgery and Implantology, Fondazione Policlinico Universitario Gemelli, Rome, Italy
| | | | - Giampiero Patriarca
- Allergy Unit, Università Cattolica del Sacro Cuore – Fondazione Policlinico “A. Gemelli”, Rome, Italy
| | - Arianna Aruanno
- Allergy Unit, Università Cattolica del Sacro Cuore – Fondazione Policlinico “A. Gemelli”, Rome, Italy
| | - Domenico Schiavino
- Allergy Unit, Università Cattolica del Sacro Cuore – Fondazione Policlinico “A. Gemelli”, Rome, Italy
| |
Collapse
|
7
|
Buonomo A, Pascolini L, Rizzi A, Aruanno A, Pecora V, Ricci AG, Mezzacappa S, Di Rienzo A, Centrone M, Nucera E, Schiavino D. Cross-reactivity and Tolerability of Ertapenem in Patients With IgE-Mediated Hypersensitivity to β-Lactams. J Investig Allergol Clin Immunol 2016; 26:100-5. [PMID: 27164625 DOI: 10.18176/jiaci.0019] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
BACKGROUND AND OBJECTIVE Administration of carbapenems to β-lactam-allergic patients has always been considered potentially harmful because of a 47.4% rate of cross-reactivity to imipenem reported in a single study. Nevertheless, recent studies have shown that the rate of cross-reactivity of imipenem and meropenem with penicillins is lower than 1%. The aim of this study was to evaluate the possibility of using ertapenem in patients with an established IgE-mediated β-lactam allergy. PATIENTS AND METHODS We studied all participants who came to our allergy unit and had a clinical history of immediate hypersensitivity reactions to β-lactams. The inclusion criteria were a positive skin test result to at least 1 β-lactam molecule and/or positive specific IgE (when available). All participants underwent immediate-type skin tests with several β-lactam molecules including ertapenem. Challenges with intravenous ertapenem were performed on 2 different days in patients with negative skin test results. RESULTS We examined 49 patients with a clinical history of immediate reactions to β-lactams. All the patients had positive skin tests and/or positive specific IgE to at least 1 β-lactam reagent and negative carbapenem skin tests. Thirty-six patients agreed to undergo the challenges and 35 tolerated the full dose of ertapenem. CONCLUSIONS The practice of avoiding carbapenems in patients with β-lactam allergy should be abandoned considering the very low rate of cross-reactivity. β-Lactam-allergic patients who need ertapenem therapy should undergo skin tests and, if negative, a graded challenge to assess tolerability.
Collapse
Affiliation(s)
- A Buonomo
- Department of Allergy, Università Cattolica del Sacro Cuore, Rome, Italy
| | - L Pascolini
- Department of Allergy, Università Cattolica del Sacro Cuore, Rome, Italy
| | - A Rizzi
- Department of Allergy, Università Cattolica del Sacro Cuore, Rome, Italy
| | - A Aruanno
- Department of Allergy, Università Cattolica del Sacro Cuore, Rome, Italy
| | - V Pecora
- Department of Allergy, Università Cattolica del Sacro Cuore, Rome, Italy
| | - A G Ricci
- Department of Allergy, Università Cattolica del Sacro Cuore, Rome, Italy
| | - S Mezzacappa
- Department of Allergy, Università Cattolica del Sacro Cuore, Rome, Italy
| | - A Di Rienzo
- Department of Allergy, Università Cattolica del Sacro Cuore, Rome, Italy
| | - M Centrone
- Department of Allergy, Università Cattolica del Sacro Cuore, Rome, Italy
| | - E Nucera
- Department of Allergy, Università Cattolica del Sacro Cuore, Rome, Italy
| | - D Schiavino
- Department of Allergy, Università Cattolica del Sacro Cuore, Rome, Italy
| |
Collapse
|
8
|
Mezzacappa S, Nucera E, Pecora V, Rizzi A, Aruanno A, Pascolini L, Ferraironi M, Ricci AG, Di Rienzo A, Centrone M, Buonomo A, Schiavino D. Profilin desensitisation in patients with adverse reaction after plant‐derived: our experience. Clin Transl Allergy 2015. [PMCID: PMC4412518 DOI: 10.1186/2045-7022-5-s3-o20] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Affiliation(s)
- Simona Mezzacappa
- Allergy DepartmentUniversità Cattolica del Sacro CuoreA. Gemelli HospitalRomeItaly
| | - Eleonora Nucera
- Allergy DepartmentUniversità Cattolica del Sacro CuoreA. Gemelli HospitalRomeItaly
| | - Valentina Pecora
- Allergy DepartmentUniversità Cattolica del Sacro CuoreA. Gemelli HospitalRomeItaly
| | - Angela Rizzi
- Allergy DepartmentUniversità Cattolica del Sacro CuoreA. Gemelli HospitalRomeItaly
| | - Arianna Aruanno
- Allergy DepartmentUniversità Cattolica del Sacro CuoreA. Gemelli HospitalRomeItaly
| | - Lucilla Pascolini
- Allergy DepartmentUniversità Cattolica del Sacro CuoreA. Gemelli HospitalRomeItaly
| | - Manuela Ferraironi
- Allergy DepartmentUniversità Cattolica del Sacro CuoreA. Gemelli HospitalRomeItaly
| | - Anna Giulia Ricci
- Allergy DepartmentUniversità Cattolica del Sacro CuoreA. Gemelli HospitalRomeItaly
| | - Alessia Di Rienzo
- Allergy DepartmentUniversità Cattolica del Sacro CuoreA. Gemelli HospitalRomeItaly
| | - Michele Centrone
- Allergy DepartmentUniversità Cattolica del Sacro CuoreA. Gemelli HospitalRomeItaly
| | - Alessandro Buonomo
- Allergy DepartmentUniversità Cattolica del Sacro CuoreA. Gemelli HospitalRomeItaly
| | - Domenico Schiavino
- Allergy DepartmentUniversità Cattolica del Sacro CuoreA. Gemelli HospitalRomeItaly
| |
Collapse
|
9
|
Addati T, Achille G, Centrone M, Petroni S, Popescu O, Russo S, Grammatica L, Simone G. TROP-2 expression in papillary thyroid cancer: a preliminary cyto-histological study. Cytopathology 2014; 26:303-11. [DOI: 10.1111/cyt.12196] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/01/2014] [Indexed: 12/30/2022]
Affiliation(s)
- T. Addati
- Anatomic Pathology Unit; National Cancer Research Centre Istituto Tumori ‘Giovanni Paolo II’; Bari Italy
| | - G. Achille
- Otorhinolaryngology Unit; National Cancer Research Centre Istituto Tumori ‘Giovanni Paolo II’; Bari Italy
| | - M. Centrone
- Anatomic Pathology Unit; National Cancer Research Centre Istituto Tumori ‘Giovanni Paolo II’; Bari Italy
| | - S. Petroni
- Anatomic Pathology Unit; National Cancer Research Centre Istituto Tumori ‘Giovanni Paolo II’; Bari Italy
| | - O. Popescu
- Anatomic Pathology Unit; National Cancer Research Centre Istituto Tumori ‘Giovanni Paolo II’; Bari Italy
| | - S. Russo
- Otorhinolaryngology Unit; National Cancer Research Centre Istituto Tumori ‘Giovanni Paolo II’; Bari Italy
| | - L. Grammatica
- Otorhinolaryngology Unit; National Cancer Research Centre Istituto Tumori ‘Giovanni Paolo II’; Bari Italy
| | - G. Simone
- Anatomic Pathology Unit; National Cancer Research Centre Istituto Tumori ‘Giovanni Paolo II’; Bari Italy
| |
Collapse
|
10
|
Bonaccini Calia D, Guidolin I, Friedenauer A, Hager M, Karpov V, Pfrommer T, Holzlöhner R, Lewis S, Hackenberg W, Lombardi G, Centrone M, Pedichini F. The ESO transportable LGS Unit for measurements of the LGS photon return and other experiments. ACTA ACUST UNITED AC 2012. [DOI: 10.1117/12.926898] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
|
11
|
Petroni S, Addati T, Giotta F, Centrone M, Mattioli E, Caponio M, Quero C, Rubini V, Giannone G, Millaku A, Simone G. Chromosome (Ch17) disorder and Ki67expression: Negative prognostic factors in invasive breast cancer. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.e21073] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
12
|
Colucci A, Aventaggiato L, Centrone M, Gagliano-Candela R. Validation of an Extraction and Gas Chromatography-Mass Spectrometry Quantification Method for Cocaine, Methadone, and Morphine in Postmortem Adipose Tissue*. J Anal Toxicol 2010; 34:342-6. [DOI: 10.1093/jat/34.6.342] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
13
|
|